← Back to Search

Face Tent Ventilation System for Risk Reduction During Pediatric Surgeries

N/A

Waitlist Available

Led By Stephanie Pan, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

children receiving anesthesia-related aerosol generating medical procedures

Be younger than 65 years old

Must not have

patients with positive COVID symptoms

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 60 minutes

Awards & highlights

No Placebo-Only Group

Summary

This trial will test how well a local exhaust ventilation system (LEVS) works to reduce exposure to infectious and smoke particulates for medical providers during anesthesia-related AGMPs and pediatric surgeries.

Who is the study for?

This trial is for children undergoing anesthesia-related procedures that create aerosols, which are tiny particles that can be inhaled. Children who have tested positive for COVID-19 or show symptoms of the virus cannot participate.

What is being tested?

The study aims to measure how much medical staff are exposed to infectious and smoke particles during certain pediatric surgeries. It will then test a local exhaust ventilation system (LEVS) to see if it reduces this exposure.

What are the potential side effects?

Since this trial tests a protective device rather than a medication, there aren't direct side effects like with drugs. However, there may be indirect effects related to comfort or visibility while using the LEVS.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child is undergoing a procedure that requires anesthesia.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am showing symptoms of COVID-19.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 60 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 60 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 60 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Aerosolized particle concentration in air

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Pediatric PatientsExperimental Treatment1 Intervention

Participants undergoing anesthesia-related aerosol generating medical procedures (AGMPs) and pediatric otolaryngologic surgeries will have a local exhaust ventilation system to the exposure seen by the medical providers during the AGMPs and surgeries.

0 / 2Eligibility criteria met